1. Thrombocytopenia caused by the development of antibodies to thrombopoietin;Li;Blood,2001
2. J.N. Mahlangu, K.N. Weldingh, S.R. Lentz, S. Kaicker, F.A. Karim, et al., Changes in the amino acid sequence of the rFVIIa analog, vatreptacog alfa, are associated with clinical immunogenicity, J. Thromb. Haemost., in press.
3. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa;Lentz;J. Thromb. Haemost.,2014
4. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII;van Haren;PLoS One,2013
5. MHC class II epitope predictive algorithms;Nielsen;Immunology,2010